“…[5,6] Pathophysiology of AKI is not clear, though multifactorial mechanisms containing ischemia-reperfusion injury, direct inflammatory injury, coagulation, endothelial cell dysfunction, and apoptosis are generally considered to be causes. [7] Agomelatine, N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide, is specified for the treatment of major depression, with dual effects on sleep problems and depressive disorders.…”